Analytical characterization and clinical evaluation of an enzyme-linked immunosorbent assay for measurement of afamin in human plasma.
Dieplinger B, Egger M, Gabriel C, Poelz W, Morandell E, Seeber B, Kronenberg F, Haltmayer M, Mueller T, Dieplinger H
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine the effects of patient age and gender, time of blood collection relative to menstrual cycle and eating, plasma storage temperature and duration, and using serum instead of plasma for the quantification of afamin. The correlation of afamin levels with levels of other clinical chemistry analytes was also investigated. Blood was collected into plain or EDTA polyethylene terephthalate glycol tubes and centrifuged to obtain serum and plasma respectively. To determine the effects of fasting, blood was collected at 7 AM (overnight fast), 11 AM, and 2 PM, with meals immediately following the 7 AM and 11 AM blood draws. To determine the effects of diurnal variation, blood was collected from non-fasting women every 4 h for a 24 h period starting at 8 AM.
Summary of Findings
Afamin levels were stable in plasma stored for up to 24 h at room temperature or 48 h at 4 degrees C, but levels declined with further storage at room temperature or 4 degrees C. In contrast, storing plasma at -20 or -80 degrees C had no effect on afamin levels. Patient age, gender, estimated glomerular filtration rate (eGFR), collecting serum rather than plasma, fasting status, time of collection, and day of menstrual cycle had no effects on levels of afamin. Heart failure, pneumonia and sepsis led to decreased levels of afamin compared to healthy individuals or those with kidney disease or chronic obstructive pulmonary disease. Afamin levels were modestly and negatively correlated with levels of CRP (r= -0.463, p<0.001) and IL-6 (r= -0.471, p< 0.001), weakly negatively correlated with levels of PCT (r= -0.234, p= 0.019), weakly associated with albumin levels (r=0.269, p= 0.007) and very weakly and negatively associated with levels of BNP(r= -0.187, p= 0.063).
Biospecimens
FluidPlasmaFluidSerumFluidBloodPreservation Types
None (Fresh)Diagnoses
Cardiovascular DiseaseChronic Obstructive Pulmonary Disease (COPD)Pneumonia/Respiratory InfectionNormalOther diagnosesPlatforms
ProteinELISAProteinClinical chemistry/auto analyzerPeptideClinical chemistry/auto analyzerSmall moleculeClinical chemistry/auto analyzerPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Biomarker level <90 mL/min eGFR>90 mL/min eGFRPreaquisition Diagnosis/ patient condition Chronic obstructive pulmonary diseaseHealthyHeart failurePneumoniaRenal diseaseSepsisPreaquisition Patient age 18-24 years25-34 years35-44 years45-54 years55-65 yearsPreaquisition Patient gender FemaleMaleBiospecimen Acquisition Time of biospecimen collection 11 AM (after eating)12 AM12 PM2 PM (after eating)4 AM4 PM7 AM (after fast)8 AM8 PMDay 10-12 of menstrual cycleDay 21-23 of menstrual cycleDay 3-5 of menstrual cycleBiospecimen Aliquots and Components Blood and blood products PlasmaSerumStorage Storage duration 0 h1 month1 week1 year12 h24 h4 h48 h6 months72 hStorage Storage temperature -20 degrees C-80 degrees C4 degrees CRoom temperature (18-25 degrees C)